The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience
- PMID: 17276613
- DOI: 10.1016/j.ijrobp.2006.11.030
The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience
Abstract
Purpose: Determine the failure patterns of oral cavity squamous cell carcinoma (SCC) treated with intensity-modulated radiotherapy (IMRT).
Methods and materials: Between May 2001 and July 2005, 55 patients with oral cavity SCC were treated with IMRT for curative intent. Forty-nine received postoperative IMRT, 5 definitive IMRT, and 1 neoadjuvant. Three target volumes were defined (clinical target CTV1, CTV2, and CTV3). The failure patterns were determined by coregistration or comparison of the treatment planning computed tomography to the images obtained at the time of recurrence.
Results: The median follow-up for all patients was 17.1 months (range, 0.27-59.3 months). The median follow-up for living patients was 23.9 months (range, 9.3-59.3 months). Nine patients had locoregional failures: 4 local failures only, 2 regional failures only, and 3 had both local and regional failures. Five patients failed distantly; of these, 3 also had locoregional failures. The 2-year overall survival, disease-specific survival, local recurrence-free survival, locoregional recurrence-free survival, and distant disease-free survival was 68%, 74%, 85%, 82%, and 89%, respectively. The median time from treatment completion to locoregional recurrence was 4.1 months (range, 3.0-12.1 months). Except for 1 patient who failed in contralateral lower neck outside the radiation field, all failed in areas that had received a high dose of radiation. The locoregional control is strongly correlated with extracapsular extension.
Conclusions: Intensity-modulated RT is effective for oral cavity SCC. Most failures are in-field failures. Further clinical studies are necessary to improve the outcomes of patients with high-risk features, particularly for those with extracapsular extension.
Similar articles
-
Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21. doi: 10.1016/j.ijrobp.2005.02.025. Int J Radiat Oncol Biol Phys. 2005. PMID: 16168834
-
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.Oral Oncol. 2013 Mar;49(3):255-60. doi: 10.1016/j.oraloncology.2012.09.006. Epub 2012 Oct 15. Oral Oncol. 2013. PMID: 23079695
-
Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):28-42. doi: 10.1016/j.ijrobp.2003.10.032. Int J Radiat Oncol Biol Phys. 2004. PMID: 15093896
-
Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research.Am J Clin Oncol. 2006 Dec;29(6):606-12. doi: 10.1097/01.coc.0000242294.89536.d6. Am J Clin Oncol. 2006. PMID: 17148999
-
The role of intensity modulated radiotherapy in advanced oral cavity carcinoma.J Cancer Res Ther. 2012 Jan;8 Suppl 1:S67-71. doi: 10.4103/0973-1482.92218. J Cancer Res Ther. 2012. PMID: 22322735 Review.
Cited by
-
Outcomes among oropharyngeal and oral cavity cancer patients treated with postoperative volumetric modulated arctherapy.Front Oncol. 2023 Oct 31;13:1272856. doi: 10.3389/fonc.2023.1272856. eCollection 2023. Front Oncol. 2023. PMID: 38023128 Free PMC article.
-
Evaluation of survival outcome and prognostic factors for oral cavity cancer treated with volumetric arc therapy.J Cancer Res Clin Oncol. 2023 Dec;149(19):16983-16992. doi: 10.1007/s00432-023-05397-4. Epub 2023 Sep 23. J Cancer Res Clin Oncol. 2023. PMID: 37740764
-
Association of ipsilateral radiation therapy with contralateral lymph node failure in patients with squamous cell carcinoma of the oral cavity: A systematic review and meta-analysis.Head Neck. 2023 Aug;45(8):1967-1974. doi: 10.1002/hed.27421. Epub 2023 May 29. Head Neck. 2023. PMID: 37246617
-
Advances in Image-Guided Radiotherapy in the Treatment of Oral Cavity Cancer.Cancers (Basel). 2022 Sep 23;14(19):4630. doi: 10.3390/cancers14194630. Cancers (Basel). 2022. PMID: 36230553 Free PMC article. Review.
-
Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.Front Oncol. 2022 Mar 24;12:817692. doi: 10.3389/fonc.2022.817692. eCollection 2022. Front Oncol. 2022. PMID: 35402268 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
